AI assistant
Sending…
RESMED INC — Director's Dealing 2016
Nov 15, 2016
30071_dirs_2016-11-15_51b39560-1871-4fef-83af-665c14f06286.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2016-11-11
Reporting Person: Hollingshead James (President, Americas)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-11-11 | ResMed Common Stock | F | 1503 | $59.85 | Disposed | 44133 | Direct |
| 2016-11-11 | ResMed Common Stock | F | 1789 | $59.85 | Disposed | 42344 | Direct |
| 2016-11-11 | ResMed Common Stock | F | 854 | $59.85 | Disposed | 41490 | Direct |
Footnotes
F1: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/13/2013.
F2: Includes 123 shares of ResMed stock purchased on 10/31/2016, through the ResMed Employee Stock Purchase Plan.
F3: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/19/2014.
F4: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/19/2015.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29